Bacteremia during neutropenia is a predictive factor for invasive fungal infection in children

Hirozumi Sano1, Ryoji Kobayashi, Daisuke Suzuki

  • 1Department of Pediatrics, Sapporo Hokuyu Hospital, Sapporo, Japan. hirozumi.sano@gmail.com

Abstract

Insights

Bacteremia following febrile episodes during neutropenia is a predictive factor for invasive fungal infection (IFI) in pediatric patients with hematologic or malignant disease. Early detection and antifungal measures are crucial for preventing IFI.

Area of Science:

  • Pediatric Hematology-Oncology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Invasive fungal infection (IFI) is a serious complication in pediatric patients with hematologic and malignant diseases.
  • IFI often follows bacteremia during neutropenic febrile episodes.
  • Predictive factors for IFI in this vulnerable population require further investigation.

Purpose of the Study:

  • To determine if bacteremia is a predictive factor for invasive fungal infection (IFI).
  • To investigate the relationship between bacteremia and IFI in pediatric patients undergoing chemotherapy or stem cell transplantation.
  • To identify risk factors for IFI in pediatric hematology-oncology patients.

Main Methods:

  • A study involving 62 pediatric patients with hematologic or malignant disease experiencing febrile episodes during neutropenia.
  • Patient-based analysis comparing clinical features of those with and without IFI.
  • Febrile episode-based analysis of 268 episodes to identify risk factors for IFI.

Main Results:

  • Patient-based analysis identified disease relapse and acute myeloid leukemia as risk factors for IFI.
  • Febrile episode-based analysis revealed bacteremia following febrile episodes during neutropenia as a potential risk factor for IFI.
  • This study highlights bacteremia as a key indicator for IFI risk.

Conclusions:

  • Bacteremia following febrile episodes during neutropenia is identified as a predictive factor for IFI in pediatric hematology-oncology patients.
  • Early detection of bacteremia warrants prompt preventive measures against IFI.
  • Intensive use of antifungal agents is recommended when bacteremia is detected in these patients.